Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 3
2010 1
2012 1
2013 3
2014 6
2015 8
2016 9
2017 17
2018 9
2019 9
2020 10
2021 8
2022 5
2023 6
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Autoinflammatory disease, systemic, with vasculitis"
Page 1
Cryoglobulinaemia.
Roccatello D, Saadoun D, Ramos-Casals M, Tzioufas AG, Fervenza FC, Cacoub P, Zignego AL, Ferri C. Roccatello D, et al. Nat Rev Dis Primers. 2018 Aug 2;4(1):11. doi: 10.1038/s41572-018-0009-4. Nat Rev Dis Primers. 2018. PMID: 30072738 Free article. Review.
This Primer focuses on mixed cryoglobulinaemia, which has a variable course and a prognosis that is primarily influenced by vasculitis-associated multiorgan damage. In addition, the underlying associated disease in itself may cause considerable mortality and morbidi …
This Primer focuses on mixed cryoglobulinaemia, which has a variable course and a prognosis that is primarily influenced by vasculitis …
Effects of rituximab therapy on B cell differentiation and depletion.
Bergantini L, d'Alessandro M, Cameli P, Vietri L, Vagaggini C, Perrone A, Sestini P, Frediani B, Bargagli E. Bergantini L, et al. Clin Rheumatol. 2020 May;39(5):1415-1421. doi: 10.1007/s10067-020-04996-7. Epub 2020 Feb 22. Clin Rheumatol. 2020. PMID: 32088800 Review.
It is largely used to treat B cell malignancies and has become standard in the management of B cell-mediated diseases such as rheumatoid arthritis and granulomatosis with polyangitis. ...A panel of biomarkers of response to treatment to monitor by flow cytometry is also su …
It is largely used to treat B cell malignancies and has become standard in the management of B cell-mediated diseases such as rheumat …
Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide.
Soriano A, Soriano M, Espinosa G, Manna R, Emmi G, Cantarini L, Hernández-Rodríguez J. Soriano A, et al. Front Immunol. 2020 Jun 3;11:865. doi: 10.3389/fimmu.2020.00865. eCollection 2020. Front Immunol. 2020. PMID: 32655539 Free PMC article. Review.
Monogenic autoinflammatory diseases are rare conditions caused by genetic abnormalities affecting the innate immunity. ...Advances in the treatment of autoinflammatory diseases have been favored by the use of new biologic agents and the performance of …
Monogenic autoinflammatory diseases are rare conditions caused by genetic abnormalities affecting the innate immunity. ...Adva …
Eye and Behcet's disease.
Ksiaa I, Abroug N, Kechida M, Zina S, Jelliti B, Khochtali S, Attia S, Khairallah M. Ksiaa I, et al. J Fr Ophtalmol. 2019 Apr;42(4):e133-e146. doi: 10.1016/j.jfo.2019.02.002. Epub 2019 Mar 5. J Fr Ophtalmol. 2019. PMID: 30850197 Review.
Behcet's disease is a chronic multisystem disorder characterized by relapsing inflammation for which the underlying histopathology is an occlusive vasculitis. ...It is clinically characterized by oral and genital ulcerations, ocular inflammatory involvement, skin le …
Behcet's disease is a chronic multisystem disorder characterized by relapsing inflammation for which the underlying histopathology is …
Autoinflammatory associated vasculitis.
Ginsberg S, Rosner I, Rozenbaum M, Slobodin G, Zilber K, Boulman N, Kaly L, Awisat A, Jiries N, Beyar-Katz O, Rimar D. Ginsberg S, et al. Semin Arthritis Rheum. 2016 Dec;46(3):367-371. doi: 10.1016/j.semarthrit.2016.07.007. Epub 2016 Jul 20. Semin Arthritis Rheum. 2016. PMID: 27612399
The skin is commonly involved with various manifestations including erysipelas like rash and urticaria. Although vasculitis has been described in many autoinflammatory diseases, it has not been recognized as a characteristic feature of these diseases a …
The skin is commonly involved with various manifestations including erysipelas like rash and urticaria. Although vasculitis has been …
Investigational drugs in systemic vasculitis.
Mirouse A, Cacoub P, Desbois AC, Comarmond C, Pagnoux C, Saadoun D. Mirouse A, et al. Expert Opin Investig Drugs. 2017 Sep;26(9):1049-1061. doi: 10.1080/13543784.2017.1361928. Epub 2017 Aug 4. Expert Opin Investig Drugs. 2017. PMID: 28758504 Review.
Treatment of systemic vasculitis is based on glucocorticoids (GC) in association with immunosuppressive therapy. ...Areas covered: In this review, we discuss investigational drugs in early phase clinical trials for induction of remission in vasculitis. …
Treatment of systemic vasculitis is based on glucocorticoids (GC) in association with immunosuppressive therapy. ...Areas cove …
New therapeutic solutions for Behçet's syndrome.
Vitale A, Rigante D, Lopalco G, Emmi G, Bianco MT, Galeazzi M, Iannone F, Cantarini L. Vitale A, et al. Expert Opin Investig Drugs. 2016 Jul;25(7):827-40. doi: 10.1080/13543784.2016.1181751. Epub 2016 May 10. Expert Opin Investig Drugs. 2016. PMID: 27163156 Review.
INTRODUCTION: Behcet's syndrome (BS) is a systemic inflammatory disorder characterized by a wide range of potential clinical manifestations with no gold-standard therapy. ...The latter will potentially provide their contribution for better clinical management …
INTRODUCTION: Behcet's syndrome (BS) is a systemic inflammatory disorder characterized by a wide range of potential clinical m …
Management of Small Vessel Vasculitides.
Lopalco G, Rigante D, Venerito V, Emmi G, Anelli MG, Lapadula G, Iannone F, Cantarini L. Lopalco G, et al. Curr Rheumatol Rep. 2016 Jun;18(6):36. doi: 10.1007/s11926-016-0580-1. Curr Rheumatol Rep. 2016. PMID: 27118389 Review.
Inflammation mediated by cells of the immune system and necrosis are the most striking features observed at the histologic level in patients with vasculitides, clinical entities classified according to pathologic findings involving different organs, to etiology, or …
Inflammation mediated by cells of the immune system and necrosis are the most striking features observed at the histologic level in patients …
Progress in pediatric vasculitis.
O'Neil KM. O'Neil KM. Curr Opin Rheumatol. 2009 Sep;21(5):538-46. doi: 10.1097/BOR.0b013e32832f13f1. Curr Opin Rheumatol. 2009. PMID: 19568171 Review.
PURPOSE OF REVIEW: To examine recent advances in the pathophysiology and therapy of pediatric vasculitis. RECENT FINDINGS: The past 2 years have been marked by significant progress in extending novel techniques to the investigation of the two most common pediatric vascu …
PURPOSE OF REVIEW: To examine recent advances in the pathophysiology and therapy of pediatric vasculitis. RECENT FINDINGS: The past 2 …
The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease Registry.
Ruscitti P, Sota J, Vitale A, Lopalco G, Iannone F, Morrone M, Giardini HAM, D'Agostin MA, Antonelli IPB, Almaghlouth I, Asfina KN, Khalil N, Sfikakis PP, Laskari K, Tektonidou M, Ciccia F, Iacono D, Riccio F, Ragab G, Hussein MA, Govoni M, Ruffilli F, Direskeneli H, Alibaz-Oner F, Giacomelli R, Navarini L, Bartoloni E, Riccucci I, Martín-Nares E, Torres-Ruiz J, Cipriani P, Di Cola I, Hernández-Rodríguez J, Gómez-Caverzaschi V, Dagna L, Tomelleri A, Makowska J, Brzezinska O, Iagnocco A, Bellis E, Caggiano V, Gaggiano C, Tarsia M, Mormile I, Emmi G, Sfriso P, Monti S, Erten Ş, Del Giudice E, Lubrano R, Conti G, Olivieri AN, Lo Gullo A, Tharwat S, Karamanakos A, Gidaro A, Maggio MC, La Torre F, Cardinale F, Ogunjimi B, Maier A, Sebastiani GD, Opris-Belinski D, Frassi M, Viapiana O, Bizzi E, Carubbi F, Fotis L, Tufan A, Kardas RC, Więsik-Szewczyk E, Jahnz-Różyk K, Fabiani C, Frediani B, Balistreri A, Rigante D, Cantarini L. Ruscitti P, et al. Semin Arthritis Rheum. 2023 Oct;62:152244. doi: 10.1016/j.semarthrit.2023.152244. Epub 2023 Jul 21. Semin Arthritis Rheum. 2023. PMID: 37517110 Free article.
OBJECTIVES: To describe clinical characteristics of patients with Still's disease treated with methotrexate (MTX) and to assess drug effectiveness evaluating change in disease activity, reduction of inflammatory markers, and glucocorticoid (GC)-sparing effect …
OBJECTIVES: To describe clinical characteristics of patients with Still's disease treated with methotrexate (MTX) and to asses …
86 results